关节疾病中的趋化因子：炎症的关键所在？
Chemokines in joint disease: the key to inflammation?
作者信息
Haringman J J, Ludikhuize J, Tak P P
机构信息
Division of Clinical Immunology and Rheumatology, F4-218, Department of Internal Medicine, Academic Medical Centre/University of Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, The Netherlands.
出版信息
Ann Rheum Dis. 2004 Oct;63(10):1186-94. doi: 10.1136/ard.2004.020529. Epub 2004 Apr 13.
Abstract
Targeting chemokines and/or chemokine receptors appears to be an intriguing new approach to treating chronic inflammatory disorders like rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, and transplant rejections. The involvement of chemokines and chemokine receptors in inflammatory joint diseases, the in vitro and in vivo characteristics of the chemokine family in inflammatory joint disease, and initial clinical data on chemokine blockade in patients with rheumatoid arthritis suggest that targeting the chemokine and chemokine receptor family might provide a new, promising antirheumatic strategy.
摘要
靶向趋化因子和/或趋化因子受体似乎是一种治疗类风湿性关节炎、炎症性肠病、多发性硬化症和移植排斥等慢性炎症性疾病的新方法。趋化因子和趋化因子受体在炎症性关节疾病中的作用、炎症性关节疾病中趋化因子家族的体外和体内特征，以及类风湿性关节炎患者趋化因子阻断的初步临床数据表明，靶向趋化因子和趋化因子受体家族可能提供一种新的、有前景的抗风湿策略。
相似文献
1
Chemokines in joint disease: the key to inflammation?关节疾病中的趋化因子：炎症的关键所在？
Ann Rheum Dis. 2004 Oct;63(10):1186-94. doi: 10.1136/ard.2004.020529. Epub 2004 Apr 13.
2
Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases.类风湿关节炎及其他系统性炎性风湿性疾病中的血管生成与趋化因子
J Cell Mol Med. 2002 Jul-Sep;6(3):357-76. doi: 10.1111/j.1582-4934.2002.tb00514.x.
3
Chemokines and angiogenesis in rheumatoid arthritis.类风湿关节炎中的趋化因子与血管生成
Front Biosci (Elite Ed). 2009 Jun 1;1(1):44-51. doi: 10.2741/E5.
4
The role of chemokines in rheumatoid arthritis and osteoarthritis.趋化因子在类风湿性关节炎和骨关节炎中的作用。
Scand J Rheumatol. 2005 Nov-Dec;34(6):415-25. doi: 10.1080/03009740500439159.
5
Chemokines in rheumatic diseases.风湿性疾病中的趋化因子。
Curr Drug Targets. 2006 Jan;7(1):91-102. doi: 10.2174/138945006775270231.
6
Chemokines and chemokine receptors as promising targets in rheumatoid arthritis.趋化因子及其受体作为类风湿关节炎治疗的潜在靶点
Front Immunol. 2023 Feb 13;14:1100869. doi: 10.3389/fimmu.2023.1100869. eCollection 2023.
7
[Treatment for rheumatoid arthritis by chemokine blockade].[通过趋化因子阻断治疗类风湿性关节炎]
Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):172-80. doi: 10.2177/jsci.39.172.
8
Chemokines and angiogenesis.趋化因子与血管生成
Curr Opin Rheumatol. 2001 May;13(3):202-8. doi: 10.1097/00002281-200105000-00009.
9
The Multifunctional Role of the Chemokine System in Arthritogenic Processes.趋化因子系统在致关节炎过程中的多功能作用。
Curr Rheumatol Rep. 2017 Mar;19(3):11. doi: 10.1007/s11926-017-0635-y.
10
The role of chemokines in inflammatory joint disease.趋化因子在炎性关节病中的作用。
J Leukoc Biol. 1996 Jan;59(1):6-12. doi: 10.1002/jlb.59.1.6.
引用本文的文献
1
Integrating natural products with modern medicine in the treatment of gouty arthritis: a review.天然产物与现代医学相结合治疗痛风性关节炎的研究综述
Inflammopharmacology. 2025 May 26. doi: 10.1007/s10787-025-01784-0.
2
High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis.高累积糖皮质激素剂量与活动期类风湿关节炎中炎症相关介质水平升高有关。
Front Immunol. 2024 Dec 18;15:1505615. doi: 10.3389/fimmu.2024.1505615. eCollection 2024.
3
Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development.类风湿关节炎多尺度、机械论模型，以实现晚期药物开发中的决策制定。
NPJ Syst Biol Appl. 2024 Nov 4;10(1):126. doi: 10.1038/s41540-024-00454-1.
4
CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis.CXCL12和CXCR4作为尿酸诱导炎症和痛风性关节炎患者的新型生物标志物
Biomedicines. 2023 Feb 21;11(3):649. doi: 10.3390/biomedicines11030649.
5
Single-Cell Analysis of Patients with Axial Spondyloarthritis After Anti-TNFα Treatment: Experimental Data and Review of the Literature.抗 TNF-α 治疗后轴性脊柱关节炎患者的单细胞分析：实验数据和文献复习。
Clin Rev Allergy Immunol. 2023 Aug;65(2):136-147. doi: 10.1007/s12016-023-08959-z. Epub 2023 Mar 8.
6
Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives.颗粒酶家族在类风湿关节炎中的作用：当前的认识和未来的展望。
Front Immunol. 2023 Feb 16;14:1137918. doi: 10.3389/fimmu.2023.1137918. eCollection 2023.
7
Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis.光声图像引导靶向类风湿关节炎的仿生纳米颗粒。
Proc Natl Acad Sci U S A. 2022 Oct 25;119(43):e2213373119. doi: 10.1073/pnas.2213373119. Epub 2022 Oct 18.
8
A Significant Reduction in the Plasma Levels and Gene Expression of CCL2 in Patients with Osteoarthritis following Intervention with Krocina™.使用Krocina™进行干预后，骨关节炎患者血浆中CCL2水平及基因表达显著降低。
Rep Biochem Mol Biol. 2022 Apr;11(1):10-19. doi: 10.52547/rbmb.11.1.10.
9
TNF-α Activating Osteoclasts in Patients with Psoriatic Arthritis Enhances the Recruitment of Osteoclast Precursors: A Plausible Role of WNT5A-MCP-1 in Osteoclast Engagement in Psoriatic Arthritis.TNF-α 激活银屑病关节炎患者的破骨细胞增强破骨细胞前体细胞的募集：WNT5A-MCP-1 在银屑病关节炎破骨细胞结合中的推测作用。
Int J Mol Sci. 2022 Jan 15;23(2):921. doi: 10.3390/ijms23020921.
10
Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside.新兴的微流控平台在骨关节炎管理中的应用：从实验台到病床边。
Theranostics. 2022 Jan 1;12(2):891-909. doi: 10.7150/thno.62685. eCollection 2022.
本文引用的文献
1
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.CP-481,715，一种强效且选择性的CCR1拮抗剂，对炎症性疾病具有潜在治疗意义。
J Biol Chem. 2003 Oct 17;278(42):40473-80. doi: 10.1074/jbc.M306875200. Epub 2003 Aug 7.
2
Inflammation and angiogenesis in osteoarthritis.骨关节炎中的炎症与血管生成
Arthritis Rheum. 2003 Aug;48(8):2173-7. doi: 10.1002/art.11094.
3
CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.CCR3的功能反应受CXCR3及其配体CXCL9、CXCL10和CXCL11的调节。
Eur J Immunol. 2003 Aug;33(8):2241-50. doi: 10.1002/eji.200323787.
4
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.趋化因子阻断与慢性炎症性疾病：类风湿关节炎患者的概念验证
Ann Rheum Dis. 2003 Aug;62(8):715-21. doi: 10.1136/ard.62.8.715.
5
Abandoned therapies and unpublished trials in rheumatoid arthritis.类风湿关节炎中被废弃的疗法及未发表的试验
Curr Opin Rheumatol. 2003 May;15(3):253-8. doi: 10.1097/00002281-200305000-00012.
6
Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis.巨噬细胞炎性蛋白-3α及其配体CCR6在类风湿性关节炎中的作用
Lab Invest. 2003 Apr;83(4):579-88. doi: 10.1097/01.lab.0000062854.30195.52.
7
Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis.滑膜细胞衍生的CXCL12在内皮细胞上表达，并在类风湿性关节炎中诱导血管生成。
J Immunol. 2003 Feb 15;170(4):2147-52. doi: 10.4049/jimmunol.170.4.2147.
8
Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules.白细胞迁移控制的新机制概念：整合素、趋化因子和连接分子的特化
J Mol Med (Berl). 2003 Jan;81(1):4-19. doi: 10.1007/s00109-002-0391-x. Epub 2002 Nov 13.
9
Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.前沿：趋化因子受体在人浆细胞上的表达谱解释了它们向靶组织的有效募集。
J Immunol. 2003 Feb 1;170(3):1136-40. doi: 10.4049/jimmunol.170.3.1136.
10
Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis.趋化因子受体在炎性关节炎中软骨表达的下调
Rheumatology (Oxford). 2003 Jan;42(1):14-8. doi: 10.1093/rheumatology/keg020.
Zotero 插件